Applied Biosystems, a division of Life Technologies Corporation, and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc., launched several new mass spectrometry tools to help laboratories in a variety of industries advance their efforts to improve public health and safety. The Cliquid 3.0 Software application and mTRAQ triplex reagents are designed to enhance food and water contaminant testing, forensic drug screening and protein biomarker research.
Cliquid 3.0 Software is an automated software application for contaminant testing and forensic analysis. It enables scientists to identify unknown compounds, expanding the scope of Cliquid software to identify the greatest number of compounds and driving the life-science industry’s most comprehensive solution for food and water contaminant testing as well as forensic drug screening for emerging variations of illicit drugs. mTRAQ triplex reagents are a set of chemical reagents that label proteins in complex samples for targeted quantitation. They make biomarker verification more accurate, doubling the throughput of analysis, which is expected to accelerate the use of increasing numbers of biomarkers in clinical settings.
These tools, which are optimized for Applied Biosystems/MDS Analytical Technologies mass spectrometers, including the AB SCIEX 5500 Systems and AB SCIEX TOF/TOF 5800 System, enable scientists to increase their ability to use mass spectrometry systems to identify and quantify compounds or contaminants. For example, food testing laboratories can detect unknown contaminants that may be present in the food supply, while forensic laboratories may be able to identify new designer street drugs in forensic investigations. In the proteomics field, researchers can more rapidly verify and validate biomarkers to support their potential use in clinical settings, including the emergence of personalized medicine.
Applied Biosystems, MDS Analytical Technologies
Filed Under: Drug Discovery
